Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01492933 · ClinicalTrials.gov registry record

Measuring Effects of Alcohol on Brain Chemistry

A clinical trial, sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA).

Terminated
Registry status
34
Enrollment target

NCT01492933: Clinical Trial study, sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA).

NCT01492933 is a clinical trial that was terminated before completion, run by National Institute on Alcohol Abuse and Alcoholism (NIAAA). The registered enrollment target is 34 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01492933 was terminated before completion, sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA).

TERMINATED
Registry status
34 participants
Enrollment target

Study Summary

Background: \- Studies show that alcohol changes the amount of many brain chemicals. These changes may be related to continued drinking, craving for alcohol, and relapse. This study will use magnetic resonance imaging (MRI) to look at brain areas and brain chemistry during an infusion of alcohol. It will also study how changes in brain chemistry relate to participant reports of feeling drunk. Objectives: \- To use magnetic resonance imaging to measure the effect of alcohol on brain chemistry Eligibility: * Individuals between 21 and 45 years of age. * Participants will be either light drinkers (1 to 14 standard alcoholic drinks per week) or heavy drinkers (20 to 40 standard alcoholic drinks per week). A standard drink is a 12-ounce beer, a 4-ounce glass of wine, or a shot of liquor. * Participants must be able to go without alcohol for at least 3 days in a row without severe withdrawal symptoms. Design: * This study requires two or three outpatient visits to the NIH Clinical Center. * Participants will have a physical exam and medical history. Blood and urine samples will be collected. Participants' alcohol drinking habits will also be assessed to determine whether they may have an alcohol use disorder. * At the first study visit, participants will have an infusion of alcohol. Blood samples will be collected to measure blood alcohol levels. * The MRI study visit will take place about 3 days after the first study visit. Participants will have an MRI scan of the brain, followed by an infusion of alcohol and another scan. Blood samples will be collected. * Participants will complete questionnaires before and after each infusion to measure their response to alcohol. * Heavy drinkers will come to the clinic for a third visit to discuss possible future treatment and any risky behavior associated with their high levels of alcohol use.

Trial Details

FieldValue
Enrollment Target 34 participants
Start Date 2011-11-22
Est. Completion 2015-02-24

Why NCT01492933 stopped before completion

NCT01492933 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 34 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT01492933 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01492933 about?

NCT01492933 is a clinical study titled "Measuring Effects of Alcohol on Brain Chemistry". Background: \- Studies show that alcohol changes the amount of many brain chemicals. These changes may be related to continued drinking, craving for alcohol, and relapse. This study will use magnetic resonance imaging (MRI) to look at brain areas and brain chemistry during an infusion of alcohol. I...

What is the current status of trial NCT01492933?

This trial is currently terminated. The enrollment target is 34 participants. The study started on 2011-11-22. Estimated completion is 2015-02-24.

Who is sponsoring clinical trial NCT01492933?

This trial is sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA), which has 93 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02897063 · 34 participants · Phase 1

    Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure

  • NCT03906617 · 34 participants · Phase 4

    Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine

  • NCT03992378 · 34 participants · NA

    Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis

  • NCT04047849 · 34 participants · Phase 4

    Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT01492933, the US trial registry maintained by the National Library of Medicine. NCT01492933 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.